Human Transporter News
- Business people for July 3 Saturday, July 2, 2011 @ 7:01PMAwards, honors and promotions for Knoxville business people.
- FYI: Business Sunday, June 26, 2011 @ 2:21AMBeautiful Brands International has announced an agreement with multi-unit developers Brad and Francy Bauer to open 25 new Smallcakes, A Cupcakery stores in North Carolina and South Carolina.
- Lifeline Scientific - Grant of options Wednesday, June 22, 2011 @ 2:10AMLifeline Scientific - Grant of options
- Absorption Systems’ Innovation in Drug Metabolism and Metabolite ID Leads to Patent Application Wednesday, June 1, 2011 @ 4:30AMAn innovative service offered by Absorption Systems, a leading preclinical CRO, resulted in one of its scientists included as an inventor on an international patent application filed by one of its customers.
- Simple sugar, lactate, is like 'candy for cancer cells': Cancer cells accelerate aging and inflammation in the body to ... Friday, May 27, 2011 @ 8:21AMResearchers have shed new light on the longstanding conundrum about what makes a tumor grow -- and how to make it stop. Interestingly, cancer cells accelerate the aging of nearby connective tissue cells to cause inflammation, which ultimately provides "fuel" for the tumor to grow and even metastasize.
- Lifeline Scientific - Issue of Equity / TVR Thursday, May 26, 2011 @ 1:03AMLifeline Scientific - Issue of Equity / TVR
- Original Canadarm makes its last space flight Friday Thursday, April 28, 2011 @ 4:40PMThe original Canadarm, which flexed its robotic muscles for the first time almost 30 years ago, is making its last trip into space on Friday before coming home.
- Genetic Risk For Major Depression Thursday, April 28, 2011 @ 9:35AMA new study reveals a novel gene associated with major depression. The research, published by Cell Press in the April 28 issue of the journal Neuron, suggests a previously unrecognized mechanism for major depression and may guide future therapeutic strategies for this debilitating mood disorder. Major depression is a psychiatric disorder that is responsible for a substantial loss in work ...
- New target structure for antidepressants on the horizon? Wednesday, April 27, 2011 @ 12:00PMGerman scientists from the Max Planck Institute for Psychiatry in Munich have compared the genomes of a total of 4,088 patients and 11,001 healthy control subjects from all over the world and identified a new risk gene variant for depression.
- Molecular Movements Of Neural Transporters: New Discoveries May Lead To Insights Into Drug Abuse And Depression Monday, April 25, 2011 @ 12:16PMA team of scientists from Columbia University College of Physicians and Surgeons and Weill Cornell Medical College has shed light on the molecular workings of transporter proteins, molecular machines embedded in the cell membranes of neurons that modulate the transfer of signals between cells and recycle neurotransmitters. The research, published in the journal Nature, reveals with unprecedented ...
- Molecular Movements of Neural Transporters Unveiled: New Discoveries May Lead to Insights Into Drug Abuse and Depression Sunday, April 24, 2011 @ 12:54PMA team of scientists from Columbia University College of Physicians and Surgeons and Weill Cornell Medical College has shed light on the molecular workings of transporter proteins, molecular machines embedded in the cell membranes of neurons that modulate the transfer of signals between cells and recycle neurotransmitters.
- Low-serotonin mice less choosy about sex of partners | Not Exactly Rocket Science Thursday, April 7, 2011 @ 8:34AMWould you prefer to have sex with males or females? It’s such a simple question, but a loaded one. Biologically, we know very little about what goes on behind such sexual choices, in humans or other animals. Socially, it’s a question that can provoke fierce debate, social stigma, and psychological anxiety. Into this minefield steps a new study from Yan Liu and Yun’ai Jiang at Beijing’s National ...
- Lifeline Scientific - Issue of Equity / TVR Wednesday, March 16, 2011 @ 2:03AMLifeline Scientific - Issue of Equity / TVR
- Free employment training available at SCCTC Saturday, March 12, 2011 @ 1:01AMThe Scioto County Career Technical Center will host a special orientation on its Lucasville campus on Thursday for people interested in the free Healthcare Entry Level Pre-employment (HELP) trainin...
- Lifeline Scientific - Admission of shares / TVR Friday, March 11, 2011 @ 1:03AMLifeline Scientific - Admission of shares / TVR
- EADS back to profit in 2010 Wednesday, March 9, 2011 @ 5:02AMEADS back to profit in 2010
- Best Images from STS-133: Discovery’s Final Mission in Pictures Tuesday, March 8, 2011 @ 1:19PMAs space shuttle Discovery prepares to return home from its final mission to space, let’s take a look back at the STS-133 mission, an historic “last” for the program’s most-traveled shuttle. “I think the legacy that this shuttle has made for herself is just nothing short than cause for celebration,” said mission specialist Michael Barratt [...]
- How Sweet It Is: Why Your Taste Cells Love Sugar So Much Monday, March 7, 2011 @ 2:34PMA new research study dramatically increases knowledge of how taste cells detect sugars, a key step in developing strategies to limit overconsumption. Scientists from the Monell Center and collaborators have discovered that taste cells have several additional sugar detectors other than the previously known sweet receptor.
- Increasing The Effectiveness Of Treatment For Pancreatic Cancer Monday, March 7, 2011 @ 3:19AMNew University of Georgia research has identified a protein that can be modified to improve the effectiveness of one of the most common drugs used to treat pancreatic cancer. The research, published in the March edition of the journal Cancer Research, found that a cell-surface protein called CNT1, which transports cancer-killing drugs into tumor cells, was reduced in function in two thirds of ...
- Norfolk Southern Named to List of America's 100 Best Corporate Citizens Friday, March 4, 2011 @ 11:28AMNorfolk Southern has been named to Corporate Responsibility Magazine's 100 Best Corporate Citizens List for 2011. Norfolk Southern ranked 79th on the magazine's 12th annual list. This is the third time NS has been on the list.
- Enhancing function of protein CNT1 increases effectiveness of cancer-killing drugs in pancreatic tumors Friday, March 4, 2011 @ 12:35AMNew University of Georgia research has identified a protein that can be modified to improve the effectiveness of one of the most common drugs used to treat pancreatic cancer.
- Santaris Adds miR-33 to Its Pipeline Via Mass General Licensing Deal Thursday, March 3, 2011 @ 10:50AMSantaris Pharma unveiled its newest microRNA therapeutic program this week having acquired intellectual property from Massachusetts General Hospital related to the use of miR-33 as a target for cardiovascular disorders including hypercholesterolemia.
- Hepregen Corporation Announces Commercial Launch of HepatoPac(TM) Microliver Platform for In Vitro ADME/Tox Applications Thursday, March 3, 2011 @ 7:14AMValidated Technology Platform Addresses Liver Toxicity Issues Which Result in Costly Drug Discovery & Development Delays
- Hepregen Corporation Announces Commercial Launch of HepatoPac(TM) Microliver Platform for In Vitro ADME/Tox Applications Thursday, March 3, 2011 @ 7:00AMMEDFORD, MA--(Marketwire - 03/03/11) - Hepregen Corporation, a leading provider of bioengineered solutions that increase success in drug development in order to improve patient safety, will launch its proprietary technology platform, HepatoPac, at the SOT 50th Anniversary Annual Meeting and ToxExpo in Washington, D.C. on March 7, 2011. HepatoPac is a microliver platform for use in clearance ...
- News From The Journal Of Clinical Investigation: March 1, 2011 Wednesday, March 2, 2011 @ 7:19AMMETABOLISM - New mechanism explains the role of growth hormone in fatty liver Non-alcoholic fatty liver disease (NAFLD) is a common condition that is linked to obesity and insulin resistance. If left untreated, this build up of fat deposits within the liver cells can lead to fibrosis and scarring of the organ. Although not completely understood, aberrant growth hormone (GH) signaling is thought ...
- MatchMaker OCR Solution by APS Technology Receives Patent Monday, February 28, 2011 @ 8:36AMSAN DIEGO , Feb. 28, 2011 /PRNewswire/ -- APS Technology Group, Inc., a leading provider of optical character recognition ( OCR ) and process automation technology solutions for marine and intermodal container terminals , announced the US Patent and Trademark Office has awarded the company a patent for the identification process surrounding its MatchMaker OCR solution for container terminal ...
- British PM sorry for Libya evacuation delay Thursday, February 24, 2011 @ 7:31PMLONDON GATWICK AIRPORT: Two British rescue flights were to depart Libya on Friday and a warship full of stranded nationals left for Malta as leader David Cameron apologised for the delay in getting them home.
- 3-D structure required for function of some vital cell transporters resolved Wednesday, February 23, 2011 @ 10:15PMResearchers have completed the 3-D structural sequence adopted by several essential proteins in the exchange of substances between the extra and intracellular milieu. This finding provides a global perspective of the structural changes that occur in these relevant proteins during basic cell processes, such as protein synthesis, the regulation of metabolism and cell volume, and nerve transmission ...
- DATTCO to run Hartford’s Dial-A-Ride Tuesday, February 22, 2011 @ 10:51AMThe City of Hartford has hired New Britain transporter DATTCO to manage the Dial-A-Ride network senior and disable residents, effective March 1.
- Mouse Study Helps Nail Down How Antidepressants Work Monday, February 21, 2011 @ 11:49AMResearchers theorize that antidepressants such as Prozac, Lexapro and Paxil work by blocking the serotonin transporter, a brain protein that normally clears away the mood-regulating chemical serotonin — but in fact, no one really knows how such drugs work. Now, a new research effort by neuroscientists at Vanderbilt University is aimed at determining how selective [...]
- New model for probing antidepressant actions Friday, February 18, 2011 @ 5:11PMHow antidepressants called selective serotonin reuptake inhibitors (SSRIs) work can be thoroughly explored with a new mouse model developed by neuroscientists. The mice express a serotonin transporter that has been genetically altered so that it does not respond to many SSRIs or cocaine. The new mouse model could also lead to the development of entirely new classes of antidepressant medications.
- New model for probing antidepressant actions Friday, February 18, 2011 @ 4:05PMmedicines such as Prozac, Lexapro and Paxil – work by blocking the serotonin transporter, a brain protein that normally clears away the mood-regulating chemical serotonin. Or so the current thinking goes.
- New model for probing antidepressant actions Friday, February 18, 2011 @ 3:43PM( Vanderbilt University Medical Center ) How antidepressants called selective serotonin reuptake inhibitors (SSRIs) work can be thoroughly explored with a new mouse model developed by neuroscientists at Vanderbilt University. The mice, described in the Proceedings of the National Academy of Sciences, express a serotonin transporter that has been genetically altered so that it does not respond to ...
- Research and Markets: In 2011 There Are 20 Companies Plus Partners Developing 20 Hedgehog Pathway Targeting Drugs in ... Monday, February 14, 2011 @ 8:35AMResearch and Markets has announced the addition of the "Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2011" report to their offering.
- FDA teams up with Optivia Biotechnology to assess supplement-drug interactions Monday, February 7, 2011 @ 11:13AMThe issue of drug and nutrient interactions is a growing area of interest for both the nutrition and pharmaceutical industries.
- Optivia Signs Agreement With U.S. FDA To Assess Role Of Dietary Supplements In Drug-Induced Liver Injury Thursday, February 3, 2011 @ 1:11AMOptivia Biotechnology Inc., a leading provider of in vitro transporter assay services, recently announced that the company and the U.S. Food and Drug Administration (FDA) have signed a collaboration agreement to assess the effect of dietary supplements on key drug transporters.
- Egypt and the false dilemma -- decline and fall Tuesday, February 1, 2011 @ 11:39PMThe people of Egypt have had enough of a failed dictatorship masquerading as a democracy. As events unfold, we’re seeing a cautionary message entering the corporate media coverage of this event.
- FDA, Optivia collaborate to examine dietary supplement role in causing drug-related liver injury Tuesday, February 1, 2011 @ 10:47PMOptivia Biotechnology, a leading provider of in vitro transporter assay services, today announced that the company and the U.S. Food and Drug Administration have signed a collaboration agreement to assess the effect of dietary supplements on key drug transporters.
- Re-Discovery; Orbiter makes second trip out to the launch pad for STS-133 Monday, January 31, 2011 @ 11:32PMCAPE CANAVERAL – Space shuttle Discovery was wheeled out of the Vehicle Assembly Building (VAB) on one of the massive crawler-transporters toward launch complex 39A – and its final mission – STS-133, currently scheduled for launch on February 24 at 4:50 p.m. EST (21:50 GMT). This marks the second trip out to the launch pad [...]
- Review: 'The Mechanic' Friday, January 28, 2011 @ 6:43AMFollowing a run of modest success with over-the-top action franchises "Crank" and "The Transporter," British tough guy Jason Statham enters the realm of remakes as hired killer Arthur Bishop in "The Mechanic."
- Feast or Famine: Researchers Identify Leptin Receptor’s Sidekick as a Target for Appetite Regulation Thursday, January 27, 2011 @ 9:32AMJACKSONVILLE, Fla.--(BUSINESS WIRE)--A study by researchers at Mayo Clinic’s campus in Florida and Washington University School of Medicine adds a new twist to the body of evidence suggesting human obesity is due in part to genetic factors. While studying hormone receptors in laboratory mice, neuroscientists identified a new molecular player responsible for the regulation of appetite and ...
- Feast or Famine: Researchers Identify Leptin Receptor’s Sidekick as a Target for Appetite Regulation Thursday, January 27, 2011 @ 9:18AMA study by researchers at Mayo Clinic’s campus in Florida and Washington University School of Medicine adds a new twist to the body of evidence suggesting human obesity is due in part to genetic factors.
- De Soto landfill issued notices by IEPA Monday, January 24, 2011 @ 11:33PMThe Illinois Environmental Protection Agency has issued violation notices to Southern Illinois Regional Landfill in De Soto for violations of the Environmental Protection Act and Illinois Regulations.
- New research provides insight into known factor that promotes cell death Monday, January 24, 2011 @ 10:52PMNew research led by UC Davis scientists provides insight into why some body organs are more susceptible to cell death than others and could eventually lead to advances in treating or preventing heart attack or stroke.
- Lifeline Scientific - Admission of shares / TVR Friday, January 21, 2011 @ 3:31AMLifeline Scientific - Admission of shares / TVR
- Gene variants predict treatment success for alcoholism medication Wednesday, January 19, 2011 @ 9:35AMThe effectiveness of an experimental treatment for alcoholism depends on the genetic makeup of individuals who receive it, according to a new study supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health. A report of the findings appears online in the American Journal of Psychiatry.
- 4 Dividend Stocks Showing You the Money Tuesday, January 18, 2011 @ 10:28AMCompanies with growing yields can make you rich in more ways than the obvious.
- Lifeline Scientific - Trading Statement Monday, January 17, 2011 @ 1:02AMLifeline Scientific - Trading Statement
- Feast Or Famine: Researchers Identify Leptin Receptor's Sidekick As A Target For Appetite Regulation Wednesday, January 12, 2011 @ 3:19PMA Mayo Clinic researcher says the surprising findings suggest the possibility of a novel treatment for obesity A study by researchers at Mayo Clinic's campus in Florida and Washington University School of Medicine adds a new twist to the body of evidence suggesting human obesity is due in part to genetic factors. While studying hormone receptors in laboratory mice, neuroscientists identified a ...
- Feast Or Famine; Researchers Identify Leptin Receptor's Sidekick As A Target For Appetite Regulation Wednesday, January 12, 2011 @ 7:26AMA study by researchers at Mayo Clinic's campus in Florida and Washington University School of Medicine adds a new twist to the body of evidence suggesting human obesity is due in part to genetic factors. While studying hormone receptors in laboratory mice, neuroscientists identified a new molecular player responsible for the regulation of appetite and metabolism. In the Jan. 11 online issue of ...